DB
ISEE

Dmitry Balyasny’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Dmitry Balyasny’s Portfolio ISEE Stock Details ISEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,202,733
Closed -$42.5M – 3113
2023
Q1 		$29.3M Buy
1,202,733
+359,422
+43% +$7.87M 0.07% 388
2022
Q4 		$18.1M Sell
843,311
-839,924
-50% -$17.9M 0.05% 526
2022
Q3 		$30.2M Buy
1,683,235
+1,180,342
+235% +$15.5M 0.09% 293
2022
Q2 		$4.84M Buy
+502,893
New +$6.31M 0.02% 953
2022
Q1 		– Sell
-33,628
Closed -$562K – 2994
2021
Q4 		$562K Buy
+33,628
New +$551K ﹤0.01% 1593
2016
Q2 		– Sell
-50,696
Closed -$2.14M – 1519
2016
Q1 		$2.14M Sell
50,696
-115,195
-69% -$5.87M 0.01% 681
2015
Q4 		$13M Sell
165,891
-143,311
-46% -$8.29M 0.09% 304
2015
Q3 		$12.5M Buy
309,202
+211,883
+218% +$11.2M 0.09% 288
2015
Q2 		$5.07M Buy
+97,319
New +$4.84M 0.03% 584

Dmitry Balyasny's ISEE Position: Q2 2023 in Review

Dmitry Balyasny sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q2 2023, closing a stake of 1,202,733 shares — an estimated $42.5M sold.

Dmitry Balyasny first reported a position in ISEE in Q2 2015 and held it in 9 quarters. The position peaked at $30.2M in Q3 2022. 256 funds tracked by Wall St. Rank hold ISEE as of Q2 2023.

  • Dmitry Balyasny reported no remaining IVERIC bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Dmitry Balyasny sold 1,202,733 IVERIC bio, Inc. Common Stock shares in Q2 2023, an estimated $42.5M.
  • Dmitry Balyasny first reported a position in IVERIC bio, Inc. Common Stock in Q2 2015 and held it in 9 quarters.
  • Dmitry Balyasny's IVERIC bio, Inc. Common Stock position peaked at $30.2M in Q3 2022.
  • 256 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q2 2023.

Based on Balyasny Asset Management's 13F filing for Q2 2023, filed 14 Aug 2023.